(Q52106214)

22 April 2018

title

The Effects of an Ergot Alkaloid Derivative (Hydergine) on Aspects of Psychomotor Performance, Arousal, and Cognitive Processing Ability (English)

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1979.TB01643.X

30 June 2023

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1979.TB01643.X

30 June 2023

author name string

I. Hindmarch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A536469

30 June 2023

A. C. Parrott

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A536469

30 June 2023

M. Lanza

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A536469

30 June 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=536469

30 June 2023

publication date

1 November 1979

1 reference

22 April 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1552-4604.1979.tb01643.x

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1979.TB01643.X

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1979.tb01643.x/fullpdf

30 June 2023

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1979.TB01643.X

The Journal of Clinical Pharmacology

30 June 2023

published in

1 reference

22 April 2018

volume

19

1 reference

22 April 2018

issue

11-12

1 reference

22 April 2018

page(s)

726-732

1 reference

22 April 2018

Two trials comparing 'Hydergine' with placebo in the treatment of patients suffering from cerebrovascular insufficiency.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1979.TB01643.X

A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1979.TB01643.X

An Ergot Alkaloid Preparation (Hydergine) in Geriatric Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1979.TB01643.X

An Ergot Alkaloid Preparation (Hydergine) versus Papaverine in Treating Common Complaints of the Aged: Double-Blind Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1979.TB01643.X

The actions of Hydergine on the brain. A histochemical, circulatory and neurophysiological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1979.TB01643.X

Possible role for cyclic nucleotides and phosphorylated membrane proteins in postsynaptic actions of neurotransmitters†

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1979.TB01643.X

Biochemical effects of ergot alkaloids with special reference to the brain

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1979.TB01643.X

A clinical trial comparing 'Hydergine' with placebo in the treatment of cerebrovascular insufficiency in elderly patients

30 June 2023

2

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1979.TB01643.X

A 1,4-benzodiazepine, temazepam (K 3917), its effect on some psychological parameters of sleep and behaviour

30 June 2023

15

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1979.TB01643.X

30 June 2023

Identifiers

1 reference

22 April 2018

1 reference

22 April 2018